Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma have?
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma has 164 citations in the OpenAlex counts ScholarIQ stores.
When was Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma published?
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma has 2015 year in the ScholarIQ index.
What is the open-access status of Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma?
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma has green oa status in the ScholarIQ index.
What is the DOI of Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma?
The DOI for Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma is on the source record.
What is the PMID of Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma?
The PMID for Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma is on the source record.
What is the OpenAlex record for Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma?
The OpenAlex for Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma is on the source record.